Search

everythinglearnresearchcommunity

for

Search:↓

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

A new gene mutation causes insulin resistance in a girl and her mother.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Children with marasmus have more resting hair follicles and thinner, less pigmented hair, showing long-term malnutrition.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Adiponectin may stimulate hair growth and could be a potential treatment for promoting hair growth.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Lower irisin levels in the blood may indicate more severe acne.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Understanding the properties of hyaluronic acid helps improve its use in facial aging treatments.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Obesity is linked to many gastrointestinal diseases and needs more research for treatment development.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Insulin resistance linked to obesity may increase COVID-19 severity.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.